Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FURIN,Furin,Wald ratio,1,0.81 [0.72-0.92],0.00069997723577999,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD302,CD302 antigen,Inverse variance weighted,9,0.89 [0.83-0.96],0.00118781765898459,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EZR,Ezrin,Wald ratio,1,1.82 [1.25-2.65],0.00188487924670853,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.93 [0.88-0.97],0.00221328293944332,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.9 [0.84-0.96],0.00246526458631118,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.11 [1.04-1.2],0.00271678873567868,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,27,1.07 [1.02-1.13],0.00374958997513182,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.97 [0.95-0.99],0.00389729269768759,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.06 [1.02-1.1],0.00557230401248598,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.82 [0.72-0.95],0.00635606312949387,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,30,1.05 [1.01-1.1],0.00704438271878488,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.09 [1.02-1.17],0.0092991317922446,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BSG,Basigin,Wald ratio,1,1.22 [1.05-1.41],0.00932823167924901,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,1.22 [1.05-1.41],0.0095962182007122,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS9,Galectin-9,Inverse variance weighted,26,1.06 [1.01-1.11],0.0128919375832596,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.71 [0.54-0.93],0.0137903290173339,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.04 [1.01-1.08],0.0158331308942247,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TCTN3,Tectonic-3,Inverse variance weighted,33,1.05 [1.01-1.1],0.0174822651335332,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.96 [0.93-0.99],0.0176752986238992,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FST,Follistatin,Inverse variance weighted,4,1.15 [1.02-1.29],0.0200993095789706,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.07 [1.01-1.14],0.0212586116214355,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.14 [1.02-1.27],0.024247832060699,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NT5E,5'-nucleotidase,Inverse variance weighted,45,0.97 [0.94-1],0.0249206802216652,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.05 [1.01-1.1],0.0252980944668461,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.94 [0.89-0.99],0.025645603243173,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL17C,Interleukin-17C,Inverse variance weighted,3,1.27 [1.03-1.57],0.0259042638434262,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.93 [0.86-0.99],0.0284616742131304,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN1,CCN family member 1,Inverse variance weighted,2,0.81 [0.67-0.98],0.0284678854445003,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,3,0.87 [0.77-0.99],0.0285533520273212,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.09 [1.01-1.17],0.0306556014154744,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PTN,Pleiotrophin,Inverse variance weighted,4,1.3 [1.02-1.65],0.0309602327607668,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RSPO1,R-spondin-1,Inverse variance weighted,5,0.9 [0.82-0.99],0.032699555192045,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OCLN,Occludin,Inverse variance weighted,2,1.19 [1.01-1.39],0.0333080153050504,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,0.68 [0.48-0.98],0.037475237849559,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.19 [1.01-1.4],0.037573275337768,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.03 [1-1.07],0.039545659022936,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.16 [1.01-1.33],0.0420426708689068,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.89 [0.8-1],0.0427395290151071,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.95 [0.9-1],0.0454468560169936,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,1.13 [1-1.28],0.0473559835575811,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.78 [0.61-1],0.0538119931360319,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COLEC12,Collectin-12,Inverse variance weighted,11,1.11 [1-1.24],0.0549197086519305,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,1.52 [0.99-2.33],0.0556102252690707,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.05 [1-1.1],0.0562241833507351,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.12 [0.99-1.26],0.0618642420550406,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.94 [0.88-1],0.0631628266196927,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,10,1.06 [1-1.13],0.0634627150349581,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.13 [0.99-1.29],0.0640826435186486,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.95 [0.91-1],0.0675037756368348,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MDK,Midkine,Inverse variance weighted,4,1.13 [0.99-1.3],0.0701860651527282,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.97 [0.93-1],0.070650400118519,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.93 [0.86-1.01],0.0706829605384186,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,19,0.95 [0.91-1],0.070741678068964,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPC5,Glypican-5,Inverse variance weighted,33,1.03 [1-1.06],0.0732708530819,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.64 [0.39-1.05],0.0762867561787788,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SELE,E-selectin,Inverse variance weighted,4,1.2 [0.98-1.46],0.0779645783721265,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.96 [0.93-1],0.0780951949891997,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.87 [0.74-1.02],0.0869101643792951,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.07 [0.99-1.16],0.0879456488760949,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.07 [0.99-1.15],0.0894593329637001,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,1.04 [0.99-1.1],0.0912494335809679,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.07 [0.99-1.16],0.0918996144065744,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.97 [0.93-1.01],0.0926735145168101,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.17 [0.97-1.41],0.0977389722840559,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL32,Interleukin-32,Inverse variance weighted,11,0.94 [0.87-1.01],0.099274780798623,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.03 [1-1.06],0.100398319182961,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL8,Interleukin-8,Inverse variance weighted,6,0.87 [0.74-1.03],0.10068691351037,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.11 [0.98-1.25],0.100804205668427,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SELENOP,Selenoprotein P,Inverse variance weighted,2,1.16 [0.97-1.39],0.10486987091972,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.85 [0.7-1.04],0.106413266307599,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.84 [0.68-1.04],0.110390543308421,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.33 [0.94-1.89],0.111575488206644,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPON2,Spondin-2,Inverse variance weighted,4,1.12 [0.97-1.29],0.116457267601099,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PI3,Elafin,Inverse variance weighted,10,0.95 [0.88-1.01],0.117573623165802,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.05 [0.99-1.12],0.119063067716761,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAT,Tissue-type plasminogen activator,Wald ratio,1,1.37 [0.92-2.05],0.120839868718419,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.15 [0.96-1.38],0.121214944287841,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.94 [0.87-1.02],0.126582511646384,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.06 [0.98-1.15],0.129514434957745,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCN1,Ficolin-1,Inverse variance weighted,28,1.03 [0.99-1.08],0.130287372006269,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18,Interleukin-18,Inverse variance weighted,16,1.11 [0.97-1.26],0.133711314417807,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.05 [0.98-1.12],0.136913202615429,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BCAN,Brevican core protein,Inverse variance weighted,3,0.94 [0.86-1.02],0.136953046736462,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.15 [0.96-1.37],0.137924328870812,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NECTIN2,Nectin-2,Inverse variance weighted,5,0.96 [0.9-1.01],0.138246289037882,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.95 [0.89-1.02],0.139458135669589,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.04 [0.99-1.11],0.143431228365493,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.96 [0.92-1.01],0.150765677583693,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINB8,Serpin B8,Inverse variance weighted,28,1.02 [0.99-1.05],0.153598139930419,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS1,Galectin-1,Inverse variance weighted,6,1.05 [0.98-1.12],0.155727479089427,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.93 [0.84-1.03],0.155984197694534,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSLN,Mesothelin,Inverse variance weighted,25,1.03 [0.99-1.07],0.156489440049655,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,APCS,Serum amyloid P-component,Inverse variance weighted,4,1.06 [0.98-1.15],0.159615933649228,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.09 [0.96-1.24],0.164984542247664,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,0.93 [0.85-1.03],0.166745512756269,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.03 [0.99-1.08],0.168435828585871,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.94 [0.87-1.02],0.169751777135024,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.91 [0.79-1.04],0.170822457152892,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNTN1,Contactin-1,Inverse variance weighted,22,1.04 [0.98-1.1],0.172272697933437,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.06 [0.97-1.17],0.173108185937637,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1.03 [0.99-1.06],0.175605315385887,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PALM2,Paralemmin-2,Inverse variance weighted,8,1.06 [0.97-1.15],0.177789738009395,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.95 [0.88-1.03],0.185576447118372,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.15 [0.93-1.43],0.186481881026006,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,0.91 [0.79-1.05],0.189532215345076,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.07 [0.97-1.19],0.191030260876228,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KITLG,Kit ligand,Wald ratio,1,0.76 [0.51-1.15],0.192376538827703,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.96 [0.89-1.02],0.192861050826359,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL15,Interleukin-15,Wald ratio,1,0.26 [0.03-1.99],0.194291763594893,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.75 [0.48-1.16],0.195874779361822,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.73 [0.45-1.18],0.197884951337703,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.95 [0.89-1.03],0.200009261733177,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.86 [0.69-1.08],0.201003162388811,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CSTB,Cystatin-B,Inverse variance weighted,28,1.03 [0.99-1.07],0.202740929788375,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,0.9 [0.76-1.06],0.204574026597481,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RSPO3,R-spondin-3,Inverse variance weighted,6,0.93 [0.84-1.04],0.206434770567881,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.11 [0.94-1.3],0.20697631909988,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.96-1.01],0.207521407589658,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RBP2,Retinol-binding protein 2,Wald ratio,1,0.8 [0.57-1.13],0.212064348254172,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.92 [0.8-1.05],0.216422933249353,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGA11,Integrin alpha-11,Inverse variance weighted,8,0.96 [0.89-1.03],0.226069212026011,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GUSB,Beta-glucuronidase,Inverse variance weighted,4,0.91 [0.79-1.06],0.228230151808194,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINA1,Alpha-1-antitrypsin,Inverse variance weighted,4,1.12 [0.93-1.35],0.228615031521221,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGRN,Agrin,Inverse variance weighted,17,0.96 [0.9-1.02],0.229845116950114,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.97 [0.91-1.02],0.230105974734497,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.79 [0.54-1.16],0.236223925935663,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.09 [0.94-1.26],0.239023171461583,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,1.04 [0.97-1.12],0.240685845249336,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.16 [0.9-1.48],0.243356467006243,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.96 [0.89-1.03],0.24679270847219,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL19,Interleukin-19,Inverse variance weighted,11,0.94 [0.85-1.04],0.24698282715904,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINA11,Serpin A11,Inverse variance weighted,31,0.98 [0.95-1.01],0.24758089417475,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MVK,Mevalonate kinase,Inverse variance weighted,2,0.8 [0.55-1.17],0.251151185766635,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,31,0.98 [0.95-1.01],0.254508912392695,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,2,0.91 [0.78-1.07],0.258938801338324,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,0.96 [0.91-1.03],0.260130532801523,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.95 [0.88-1.04],0.262424761142054,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,18,0.98 [0.93-1.02],0.265038588490069,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.97 [0.91-1.03],0.266022010987846,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGA4,Pepsin A-4,Inverse variance weighted,2,1.17 [0.89-1.54],0.267318220798055,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.09 [0.94-1.26],0.268624518187951,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.91 [0.76-1.08],0.272185463521663,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.02 [0.98-1.06],0.272262822456033,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,1.05 [0.96-1.16],0.273125424008238,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CST3,Cystatin-C,Inverse variance weighted,10,1.04 [0.97-1.12],0.273399236604304,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.97 [0.91-1.03],0.275432394942005,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.03 [0.98-1.09],0.278470673888489,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.03 [0.98-1.08],0.278666566262631,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.81 [0.56-1.19],0.28266679295447,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.05 [0.96-1.14],0.285554597069315,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN4,CCN family member 4,Inverse variance weighted,27,1.02 [0.98-1.06],0.287940157041473,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,13,1.04 [0.97-1.12],0.294103914688177,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS2,Trypsin-2,Inverse variance weighted,3,1.07 [0.94-1.22],0.294210659772591,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.88 [0.69-1.12],0.294438468945941,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VWC2,Brorin,Inverse variance weighted,22,0.97 [0.91-1.03],0.297265044661693,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.03 [0.97-1.1],0.300346929566648,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.95 [0.86-1.05],0.302459836026162,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.08 [0.93-1.26],0.305590345026616,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.79 [0.51-1.24],0.30735204598943,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.97 [0.9-1.03],0.312159508237128,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.95 [0.85-1.06],0.315795052064834,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1.02 [0.98-1.07],0.316863286153818,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.81 [0.53-1.23],0.317025493276862,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.04 [0.96-1.13],0.317316610723996,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,0.94 [0.84-1.06],0.31759267990134,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.02 [0.98-1.05],0.31877982340636,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTA4H,Leukotriene A-4 hydrolase,Inverse variance weighted,2,1.1 [0.91-1.32],0.320988951773772,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.17 [0.86-1.59],0.322179520477889,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN3,CCN family member 3,Inverse variance weighted,19,1.03 [0.97-1.1],0.325072539519125,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [0.98-1.06],0.332870863499924,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.04 [0.96-1.14],0.336345533218966,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.76 [0.43-1.34],0.337727858964503,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNC,Tenascin,Inverse variance weighted,12,0.97 [0.91-1.03],0.339120455708523,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSF,Cathepsin F,Inverse variance weighted,10,0.96 [0.89-1.04],0.341513655512301,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.95 [0.87-1.05],0.342199539512809,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF9,Protein turtle homolog A,Inverse variance weighted,10,0.97 [0.91-1.03],0.345352387335334,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.03 [0.97-1.11],0.348724736492221,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB1A1,Uteroglobin,Inverse variance weighted,12,0.97 [0.9-1.04],0.352519489984037,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.03 [0.97-1.1],0.35273640187766,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PYY,Peptide YY,Inverse variance weighted,6,0.96 [0.89-1.04],0.353379407669965,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.07 [0.93-1.23],0.355722065262269,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.95 [0.86-1.05],0.356099164373687,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.05 [0.95-1.16],0.356389183595412,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.97 [0.92-1.03],0.357246377859599,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GLO1,Lactoylglutathione lyase,Inverse variance weighted,13,1.03 [0.97-1.1],0.35803873566559,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.97 [0.9-1.04],0.358832169957168,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,0.96 [0.89-1.04],0.359804486422571,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.94 [0.81-1.08],0.361343595440119,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,0.98 [0.95-1.02],0.362807554392739,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.15 [0.85-1.55],0.364792541296199,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.09 [0.91-1.3],0.365633524110899,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.25 [0.77-2.02],0.366662842555253,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.05 [0.94-1.18],0.3684928200349,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.99 [0.97-1.01],0.372088673920687,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAYN,Layilin,Inverse variance weighted,20,1.03 [0.96-1.1],0.37317022634446,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,9,1.09 [0.9-1.33],0.37473858116726,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1.02 [0.98-1.05],0.377039360547692,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RAP,Interleukin-1 receptor accessory protein,Inverse variance weighted,24,0.99 [0.96-1.01],0.379876412294417,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.95 [0.85-1.06],0.38023791405615,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.96 [0.89-1.05],0.384426826767226,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.98 [0.94-1.02],0.38605702587973,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.12 [0.87-1.44],0.387462974880658,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPA1,Pulmonary surfactant-associated protein A1,Inverse variance weighted,6,0.97 [0.91-1.04],0.397479147873429,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.03 [0.96-1.1],0.397788200931114,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.9 [0.7-1.15],0.399552921653344,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.93 [0.78-1.11],0.402759498463282,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.91 [0.72-1.14],0.402822197321577,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NCAM1,Neural cell adhesion molecule 1,Inverse variance weighted,20,0.98 [0.93-1.03],0.409798264667247,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.03 [0.96-1.11],0.410596900168689,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD276,CD276 antigen,Inverse variance weighted,20,0.99 [0.95-1.02],0.412182766689766,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.02 [0.98-1.05],0.412835892492347,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD83,CD83 antigen,Inverse variance weighted,5,0.95 [0.83-1.08],0.413463100594746,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.01 [0.98-1.05],0.416107204902712,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,34,0.99 [0.95-1.02],0.416766887669799,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.05 [0.93-1.2],0.418791731651038,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SEPTIN8,Septin-8,Inverse variance weighted,2,1.12 [0.85-1.48],0.42115873112308,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,0.99 [0.96-1.02],0.4215243149166,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,26,1.01 [0.98-1.05],0.422074405277339,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.11 [0.86-1.45],0.425025871370931,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.09 [0.88-1.35],0.425723576635306,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FUOM,Fucose mutarotase,Inverse variance weighted,3,0.93 [0.77-1.12],0.426558396241053,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GRN,Progranulin,Inverse variance weighted,7,1.04 [0.95-1.14],0.42801603925199,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.09 [0.88-1.36],0.429231806317961,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.06 [0.91-1.24],0.429560943500465,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,42,1.01 [0.98-1.04],0.431612923436502,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1.03 [0.96-1.1],0.433276980149628,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.96 [0.88-1.06],0.435767437637934,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.06 [0.91-1.23],0.437878910448609,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.98 [0.92-1.04],0.439891025222233,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,C7,Complement component C7,Inverse variance weighted,38,1.01 [0.98-1.05],0.441175665711288,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDH2,Cadherin-2,Inverse variance weighted,3,0.92 [0.74-1.14],0.444334031785294,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD27,CD27 antigen,Inverse variance weighted,9,0.97 [0.9-1.05],0.446154878779439,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.95 [0.82-1.09],0.446594571879249,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,1.01 [0.98-1.05],0.447102530081503,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1.02 [0.97-1.06],0.449410802737731,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,0.97 [0.88-1.06],0.456780509226169,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.01 [0.98-1.05],0.458658846111474,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.99 [0.96-1.02],0.460304055132557,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.03 [0.95-1.13],0.46791929438691,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNTN5,Contactin-5,Inverse variance weighted,28,0.99 [0.95-1.02],0.469723228939554,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NFASC,Neurofascin,Inverse variance weighted,15,0.98 [0.93-1.03],0.471249786249553,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,4,0.96 [0.87-1.07],0.473661002758205,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP10,Stromelysin-2,Inverse variance weighted,22,0.98 [0.92-1.04],0.473688568576005,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.01 [0.97-1.06],0.47946314664069,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.03 [0.94-1.13],0.480078836373287,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.97 [0.88-1.06],0.481045735062619,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.01 [0.98-1.05],0.482082741390833,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,8,0.97 [0.89-1.06],0.490424760850484,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.02 [0.96-1.1],0.492114279590971,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NCAN,Neurocan core protein,Inverse variance weighted,3,0.95 [0.83-1.09],0.495546942116272,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.01 [0.97-1.06],0.496639120546507,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.96 [0.87-1.07],0.497292231374064,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,29,1.01 [0.98-1.04],0.49770294710242,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,0.97 [0.9-1.05],0.500468301816635,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.98 [0.93-1.03],0.502902544591915,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.98 [0.93-1.04],0.506451089324875,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.94 [0.77-1.14],0.506538059803203,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.98 [0.91-1.05],0.510136476829061,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS4,Galectin-4,Inverse variance weighted,4,1.06 [0.88-1.29],0.511834138808336,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.23 [0.67-2.26],0.511958982030666,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.02 [0.96-1.08],0.515897656703139,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.89 [0.63-1.26],0.515996301858985,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CBLN4,Cerebellin-4,Inverse variance weighted,11,1.02 [0.96-1.09],0.516069500667248,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AMBP,Protein AMBP,Inverse variance weighted,3,1.07 [0.87-1.31],0.516895294977962,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1.09 [0.84-1.43],0.517576983446921,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.95 [0.81-1.11],0.518153393362512,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.97 [0.88-1.07],0.519951655619319,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.01 [0.98-1.05],0.523301387336094,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AREG,Amphiregulin,Inverse variance weighted,3,0.96 [0.84-1.09],0.523774910633995,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,0.97 [0.86-1.08],0.524669887286855,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.93 [0.73-1.18],0.526306350948519,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.98 [0.9-1.05],0.52709477491344,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.06 [0.89-1.25],0.529423466054046,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,1.06 [0.88-1.28],0.529423466054047,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.01 [0.98-1.04],0.531196679826251,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.91 [0.66-1.23],0.531819900040166,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.04 [0.92-1.17],0.532387479819268,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.01 [0.98-1.05],0.536222516647658,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLITRK1,SLIT and NTRK-like protein 1,Wald ratio,1,1.06 [0.87-1.29],0.53885197777325,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.01 [0.98-1.05],0.539961311419487,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.02 [0.95-1.1],0.541502327582655,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK10,Kallikrein-10,Inverse variance weighted,15,1.02 [0.96-1.09],0.543966303124042,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.99 [0.95-1.03],0.546979585949318,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,1.08 [0.83-1.42],0.550499086535939,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.96-1.02],0.551989406800877,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LMNB2,Lamin-B2,Wald ratio,1,0.86 [0.52-1.42],0.551996897925828,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PVR,Poliovirus receptor,Inverse variance weighted,27,1.01 [0.98-1.04],0.552079209516724,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSM,Oncostatin-M,Wald ratio,1,0.91 [0.68-1.23],0.552198017388964,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CFI,Complement factor I,Inverse variance weighted,6,1.03 [0.94-1.13],0.559662053731491,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.01 [0.97-1.06],0.561607424419606,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,13,1.02 [0.95-1.09],0.56665990253689,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.01 [0.98-1.04],0.567945864585958,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.97 [0.88-1.08],0.570484854421138,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.1 [0.79-1.53],0.572492936961654,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,0.92 [0.67-1.24],0.573529996725215,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,5,0.98 [0.9-1.06],0.584838336142343,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.97 [0.85-1.09],0.585206470147784,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,0.98 [0.91-1.06],0.586856777334477,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLGN,Calmegin,Inverse variance weighted,23,0.99 [0.96-1.03],0.588929476149221,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.94 [0.74-1.19],0.599290836429364,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.02 [0.93-1.12],0.603862502789591,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,23,0.99 [0.95-1.03],0.604972583040168,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GAL,Galanin peptides,Inverse variance weighted,3,0.94 [0.72-1.21],0.608823762839346,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1.04 [0.9-1.21],0.609796887805772,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,0.99 [0.97-1.02],0.611418839789606,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.98 [0.89-1.07],0.61227272351636,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.08 [0.8-1.45],0.616128330654204,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP7,Matrilysin,Inverse variance weighted,13,1.01 [0.96-1.07],0.618199895765376,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGF,Placenta growth factor,Inverse variance weighted,2,1.15 [0.67-1.97],0.621472087967357,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.96 [0.82-1.13],0.622127347828037,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS3,Galectin-3,Inverse variance weighted,25,0.99 [0.95-1.03],0.622726997831603,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.05 [0.86-1.3],0.623137140777586,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.01 [0.96-1.07],0.623158903870609,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.91 [0.62-1.33],0.625978631857516,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,0.97 [0.87-1.09],0.627546615572962,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,1.11 [0.73-1.67],0.627719727833419,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,0.99 [0.94-1.04],0.627949346543361,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.02 [0.95-1.1],0.63074313366682,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.02 [0.95-1.09],0.633269925327583,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.02 [0.93-1.12],0.640710664143798,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,17,1.01 [0.97-1.05],0.641882480958802,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,4,0.96 [0.8-1.14],0.642548401013447,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,1.05 [0.85-1.31],0.644531368981683,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.02 [0.93-1.12],0.645153752107413,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.98 [0.89-1.08],0.645425000862314,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDN1,Endothelin-1,Inverse variance weighted,3,1.02 [0.93-1.12],0.648715103936031,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.98 [0.88-1.08],0.652044986131938,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.97-1.04],0.653511033611105,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.06 [0.82-1.36],0.653655650902383,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.01 [0.95-1.08],0.655333303455391,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.03 [0.91-1.16],0.657972593511082,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.99 [0.94-1.04],0.667426688458566,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSL,Cathepsin L1,Wald ratio,1,0.91 [0.58-1.42],0.670704186927131,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.99 [0.96-1.03],0.673784463782749,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK4,Kallikrein-4,Inverse variance weighted,17,0.99 [0.94-1.04],0.678496955598524,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.99 [0.97-1.02],0.680019165699968,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G1B,Phospholipase A2,Wald ratio,1,0.93 [0.65-1.33],0.691937794908816,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.02 [0.93-1.11],0.692985468618377,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.01 [0.95-1.08],0.694540102449929,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,1.01 [0.95-1.08],0.695589129677015,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.99 [0.93-1.05],0.695823488648514,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGMN,Legumain,Inverse variance weighted,12,1.02 [0.93-1.11],0.697140993513616,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CST7,Cystatin-F,Inverse variance weighted,39,0.99 [0.96-1.03],0.697243912993985,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.06 [0.78-1.44],0.699330648885772,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNR,Tenascin-R,Inverse variance weighted,16,1.01 [0.96-1.06],0.699355146682567,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHGA,Chromogranin-A,Inverse variance weighted,3,1.02 [0.91-1.16],0.702264614492808,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANXA10,Annexin A10,Wald ratio,1,0.92 [0.62-1.39],0.703044780388155,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.98 [0.9-1.08],0.705126424796155,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.03 [0.9-1.17],0.707968935491468,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.99 [0.95-1.04],0.708172171876025,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GLB1,Beta-galactosidase,Inverse variance weighted,5,1.02 [0.94-1.1],0.710233037193749,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.01 [0.95-1.08],0.716623527714888,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CALCA,Calcitonin,Inverse variance weighted,5,1.03 [0.86-1.23],0.718021253587833,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.01 [0.97-1.04],0.725016250188215,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.01 [0.96-1.06],0.725383179157785,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,0.97 [0.82-1.15],0.725890825348434,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.01 [0.97-1.04],0.734506447945318,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KYNU,Kynureninase,Inverse variance weighted,8,1.02 [0.93-1.11],0.735043087371349,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.98 [0.85-1.12],0.735145425847822,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,0.98 [0.85-1.12],0.739838875530764,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ELN,Elastin,Inverse variance weighted,2,0.95 [0.73-1.26],0.741271206118609,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.99 [0.91-1.07],0.741300178079634,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.02 [0.89-1.18],0.74361755424309,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,1.01 [0.94-1.1],0.743907981201099,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.01 [0.95-1.07],0.746301198973831,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.92 [0.53-1.57],0.747358522360819,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.01 [0.96-1.06],0.750564702022751,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.99 [0.93-1.05],0.756621867419369,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.93 [0.57-1.51],0.761550515493992,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.03 [0.84-1.27],0.761642005215555,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.98 [0.87-1.11],0.763167460514103,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.98 [0.86-1.12],0.7648173113555,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.13 [0.49-2.6],0.768696242947446,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.99 [0.91-1.07],0.770010570465291,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.01 [0.93-1.11],0.770183058406796,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GSN,Gelsolin,Inverse variance weighted,5,0.98 [0.83-1.15],0.770368780858916,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.01 [0.96-1.06],0.772653526896233,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.98 [0.86-1.12],0.774560236665951,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REN,Renin,Inverse variance weighted,4,0.99 [0.92-1.06],0.774628070154729,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.02 [0.89-1.18],0.780875777666528,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.07 [0.67-1.69],0.78174036284882,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,0.99 [0.95-1.04],0.787047444354232,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.97 [0.77-1.22],0.788404769347258,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD48,CD48 antigen,Inverse variance weighted,18,1 [0.96-1.03],0.793618211065022,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.98 [0.82-1.16],0.795923875879243,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1 [0.98-1.03],0.79762618584853,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,1 [0.97-1.04],0.801934083605803,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,19,1 [0.98-1.03],0.805952839304821,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1 [0.98-1.03],0.806539866897327,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSTN,Growth/differentiation factor 8,Inverse variance weighted,2,1.02 [0.89-1.15],0.815169064130816,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1 [0.98-1.02],0.818113248970262,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MFGE8,Lactadherin,Inverse variance weighted,11,1.01 [0.95-1.07],0.819323005581196,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.01 [0.93-1.09],0.819410377892877,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GFRAL,GDNF family receptor alpha-like,Inverse variance weighted,33,1 [0.97-1.04],0.820633212743813,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1 [0.98-1.03],0.821706263599497,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK11,Kallikrein-11,Inverse variance weighted,6,1.01 [0.95-1.06],0.830414129166117,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,0.99 [0.9-1.09],0.832781286279538,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.98 [0.82-1.17],0.832950894953038,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.98 [0.83-1.17],0.839849403055439,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,1 [0.97-1.03],0.844376601951675,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1 [0.96-1.04],0.848893071544202,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TTR,Transthyretin,Inverse variance weighted,3,0.98 [0.84-1.16],0.853453297407736,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MATN2,Matrilin-2,Inverse variance weighted,18,1.01 [0.94-1.08],0.853510710662771,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,UMOD,Uromodulin,Inverse variance weighted,29,1 [0.97-1.03],0.856881022625315,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGAV,Integrin alpha-V,Inverse variance weighted,5,0.99 [0.85-1.14],0.860247211558292,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM3B,Protein FAM3B,Inverse variance weighted,18,1 [0.97-1.04],0.867319923387685,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLG,Plasminogen,Inverse variance weighted,20,1 [0.95-1.06],0.869594834275733,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.99 [0.85-1.14],0.872407119389351,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1 [0.96-1.05],0.873561665722874,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1 [0.95-1.05],0.873989504303555,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACY1,Aminoacylase-1,Inverse variance weighted,4,0.99 [0.87-1.12],0.87511227576238,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.01 [0.91-1.11],0.882175404497797,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1 [0.97-1.03],0.88822228158667,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1 [0.97-1.03],0.888308749959143,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1 [0.97-1.04],0.890675068754393,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1 [0.94-1.05],0.89345895952855,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.03 [0.69-1.53],0.896061395211454,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1 [0.94-1.06],0.897804070885976,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1 [0.95-1.05],0.901096574425602,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1 [0.96-1.04],0.903592234714193,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,9,1.01 [0.92-1.1],0.906943398185953,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS8,Prostasin,Inverse variance weighted,5,0.99 [0.86-1.15],0.910102332721114,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.01 [0.81-1.26],0.912520760045579,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.01 [0.87-1.16],0.913546514915277,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1 [0.98-1.02],0.914129659887849,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC3B,Tetranectin,Inverse variance weighted,7,1 [0.92-1.09],0.914213400592925,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,4,0.99 [0.85-1.15],0.914266248846045,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.02 [0.7-1.48],0.914864854300611,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.01 [0.89-1.14],0.919635342272805,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,1.01 [0.86-1.18],0.92382717443515,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,21,1 [0.93-1.08],0.924006692729757,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,1 [0.97-1.03],0.92716110425139,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.99 [0.74-1.31],0.927804811608053,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,10,1 [0.93-1.07],0.929027398015866,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD248,Endosialin,Inverse variance weighted,2,0.98 [0.64-1.5],0.929994680020175,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1 [0.97-1.03],0.934450120588706,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.01 [0.73-1.41],0.936371017019456,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1 [0.96-1.05],0.93859452762054,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MME,Neprilysin,Inverse variance weighted,3,1.01 [0.74-1.37],0.943500886761542,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,4,1.01 [0.86-1.17],0.948315803173076,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.01 [0.78-1.31],0.948644566601521,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGA5,Integrin alpha-5,Wald ratio,1,1.01 [0.71-1.43],0.951521587881294,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PSAP,Prosaposin,Inverse variance weighted,5,1 [0.89-1.11],0.951784615775941,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANG,Angiogenin,Inverse variance weighted,19,1 [0.96-1.05],0.955435090973079,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,THBS2,Thrombospondin-2,Inverse variance weighted,16,1 [0.95-1.05],0.960891135456799,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CES1,Liver carboxylesterase 1,Inverse variance weighted,15,1 [0.95-1.05],0.961265760837745,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSD,Cathepsin D,Inverse variance weighted,17,1 [0.94-1.06],0.961269545399577,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1 [0.87-1.14],0.963846576219803,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TCN2,Transcobalamin-2,Inverse variance weighted,34,1 [0.97-1.03],0.967186922580062,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1 [0.96-1.04],0.968832556652968,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1 [0.83-1.21],0.971342781306383,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL5,C-C motif chemokine 5,Inverse variance weighted,2,1 [0.83-1.21],0.972702213691915,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1 [0.95-1.05],0.973664531700663,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1 [0.92-1.08],0.978822914715859,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,1 [0.97-1.03],0.97893368491075,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,THOP1,Thimet oligopeptidase,Inverse variance weighted,5,1 [0.9-1.11],0.979548680375929,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,15,1 [0.94-1.06],0.980464199171191,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,1 [0.83-1.2],0.981081134136971,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.95-1.05],0.981326126213217,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1 [0.95-1.05],0.983207495978166,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CREG1,Protein CREG1,Inverse variance weighted,3,1 [0.89-1.12],0.983950014171249,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1 [0.96-1.05],0.984896912965673,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF1,Trefoil factor 1,Inverse variance weighted,8,1 [0.93-1.08],0.985951769233313,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,1 [0.95-1.06],0.987892948152459,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1 [0.94-1.06],0.9881122281627,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1 [0.94-1.07],0.988499666463747,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1 [0.81-1.23],0.989275719516908,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1 [0.9-1.11],0.993225926592658,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDHR2,Cadherin-related family member 2,Inverse variance weighted,2,1 [0.82-1.22],0.99360919322719,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1 [0.83-1.2],0.996878987621428,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1 [0.94-1.07],0.99939537150041,cis
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,C7,Complement component C7,Inverse variance weighted,26,1.13 [1.07-1.18],1.15774034177011e-06,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RSPO1,R-spondin-1,Inverse variance weighted,8,1.21 [1.07-1.35],0.00168135002781658,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.69 [0.54-0.87],0.00224922035705552,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS9,Galectin-9,Inverse variance weighted,36,1.07 [1.02-1.12],0.0028219149273288,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,48,1.07 [1.02-1.12],0.00333953304055432,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PVR,Poliovirus receptor,Inverse variance weighted,3,0.67 [0.5-0.89],0.00664923521324484,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.27 [1.06-1.51],0.00830884231206686,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSL,Cathepsin L1,Inverse variance weighted,29,0.9 [0.84-0.97],0.00871959047057882,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.89 [0.82-0.97],0.00878548624606924,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.25 [1.06-1.48],0.00949616268145108,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,0.66 [0.48-0.9],0.00965207878844294,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.15 [1.03-1.28],0.0117619504450032,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.09 [1.02-1.17],0.0121410278936293,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL19,Interleukin-19,Inverse variance weighted,10,1.09 [1.02-1.17],0.012765634823332,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.9 [0.82-0.98],0.0155100261571507,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,0.58 [0.37-0.9],0.016401751026153,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MFGE8,Lactadherin,Inverse variance weighted,15,1.14 [1.02-1.27],0.0169608183398636,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TCTN3,Tectonic-3,Inverse variance weighted,44,1.05 [1.01-1.08],0.0196692508084448,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FST,Follistatin,Wald ratio,1,0.61 [0.4-0.92],0.0201464242757066,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,1.29 [1.04-1.61],0.0205141077494989,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G1B,Phospholipase A2,Inverse variance weighted,20,1.1 [1.01-1.2],0.0228995383667683,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL28,C-C motif chemokine 28,Inverse variance weighted,30,1.08 [1.01-1.15],0.0240644873695274,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB1A1,Uteroglobin,Inverse variance weighted,38,1.09 [1.01-1.17],0.0251031364102441,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,21,0.9 [0.81-0.99],0.0253197200182322,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.93 [0.88-0.99],0.0278500101755793,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.95 [0.91-1],0.0328420779837952,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.78 [0.62-0.98],0.0338294304556727,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACY1,Aminoacylase-1,Inverse variance weighted,6,0.83 [0.69-0.99],0.0343115877125726,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.93 [0.86-1],0.0388807585796073,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.15 [1.01-1.32],0.0407798423700403,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.22 [1.01-1.48],0.042961793150308,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.76 [0.58-0.99],0.0451512195169438,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GAL,Galanin peptides,Inverse variance weighted,49,1.06 [1-1.11],0.0462099869310546,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,20,1.08 [1-1.16],0.0475659090470568,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.93 [0.87-1],0.0491072219935003,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.65 [0.42-1],0.0498432855537228,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.27 [1-1.61],0.0515301072214654,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK11,Kallikrein-11,Inverse variance weighted,13,1.11 [1-1.23],0.0520183890940198,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.14 [1-1.3],0.055681751393442,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.14 [1-1.31],0.0567142005255059,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.74 [0.54-1.01],0.0567836525624597,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPC5,Glypican-5,Inverse variance weighted,42,1.03 [1-1.07],0.0575889323393168,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHGA,Chromogranin-A,Inverse variance weighted,5,0.84 [0.69-1.01],0.0591261353091206,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.97 [0.93-1],0.0611472448969214,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL22,Interleukin-22,Inverse variance weighted,4,1.27 [0.99-1.64],0.061166518383628,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL8,Interleukin-8,Inverse variance weighted,8,0.9 [0.81-1.01],0.0614238942467684,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,6,0.86 [0.73-1.01],0.0623842155939562,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GFRAL,GDNF family receptor alpha-like,Inverse variance weighted,25,0.95 [0.91-1],0.0636284813787479,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.93 [0.86-1],0.064422511331647,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.85 [0.71-1.01],0.065937552738044,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.65 [0.41-1.03],0.0666239732805264,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.81 [0.65-1.02],0.0684914771466777,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.82 [0.67-1.02],0.0732276228084763,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.11 [0.99-1.23],0.0744428655944245,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.23 [0.98-1.54],0.0781845113774005,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,10,1.12 [0.99-1.27],0.0782965373477434,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.12 [0.99-1.26],0.0785948111918844,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.1 [0.99-1.23],0.0791960087724753,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COLEC12,Collectin-12,Inverse variance weighted,3,0.77 [0.58-1.03],0.079755313735256,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SELENOP,Selenoprotein P,Inverse variance weighted,3,0.75 [0.54-1.04],0.0826563448560945,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,0.87 [0.74-1.02],0.0839748195367132,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.11 [0.99-1.24],0.0870064850669916,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGRN,Agrin,Inverse variance weighted,14,0.87 [0.74-1.02],0.0896905207236662,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.1 [0.99-1.22],0.0898068213747507,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CSTB,Cystatin-B,Inverse variance weighted,23,1.04 [0.99-1.08],0.090683521172374,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,24,1.05 [0.99-1.1],0.0915409620785438,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.18 [0.97-1.43],0.0954727717248588,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.07 [0.99-1.17],0.0966940786215849,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.81 [0.62-1.04],0.0988199188679596,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.7 [0.45-1.08],0.105077216109558,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TTR,Transthyretin,Inverse variance weighted,11,1.09 [0.98-1.21],0.105906020846163,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BSG,Basigin,Inverse variance weighted,6,1.16 [0.97-1.4],0.109153207015458,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.82 [0.64-1.05],0.11097848458169,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.94 [0.87-1.02],0.117231193372417,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.06 [0.98-1.14],0.119499272854347,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.94 [0.88-1.02],0.122877409460695,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.95 [0.9-1.01],0.12848625792224,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,22,1.05 [0.99-1.12],0.129135257476229,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.02 [0.99-1.04],0.13191115438043,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.82 [0.63-1.06],0.133655108130678,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.87 [0.72-1.04],0.13379104771369,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.26 [0.93-1.7],0.136090155255739,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.93 [0.84-1.02],0.136687467086224,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.16 [0.95-1.42],0.137153908220647,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.07 [0.98-1.18],0.139951950386336,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLG,Plasminogen,Inverse variance weighted,6,0.85 [0.69-1.05],0.140243405923502,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.02 [0.99-1.05],0.144662303721101,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.3 [0.91-1.86],0.145949993473531,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.04 [0.98-1.1],0.152163567923113,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.86 [0.69-1.06],0.15300401563246,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OMD,Osteomodulin,Inverse variance weighted,15,0.93 [0.84-1.03],0.156876688430693,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.76 [0.51-1.11],0.15787823781197,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINB8,Serpin B8,Inverse variance weighted,29,1.02 [0.99-1.05],0.159338473841028,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.92 [0.82-1.03],0.1611428450606,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL6,Interleukin-6,Inverse variance weighted,6,0.92 [0.83-1.03],0.161253696315309,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RSPO3,R-spondin-3,Inverse variance weighted,5,0.88 [0.73-1.05],0.163404552960525,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD302,CD302 antigen,Inverse variance weighted,11,0.91 [0.79-1.04],0.166004021791397,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS2,Trypsin-2,Inverse variance weighted,17,1.08 [0.97-1.19],0.168385115343024,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCN1,Ficolin-1,Inverse variance weighted,50,1.03 [0.99-1.07],0.171715952824783,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,1.35 [0.88-2.09],0.173695394729514,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EZR,Ezrin,Wald ratio,1,1.34 [0.87-2.07],0.177802769266747,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ELN,Elastin,Inverse variance weighted,10,1.11 [0.95-1.29],0.178217012937175,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AMBP,Protein AMBP,Inverse variance weighted,5,1.11 [0.95-1.29],0.184176745943425,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.75 [0.49-1.15],0.185699491159219,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.06 [0.97-1.16],0.186870758092076,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.17 [0.93-1.48],0.189244378495205,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,1.02 [0.99-1.06],0.19415876971582,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KITLG,Kit ligand,Inverse variance weighted,30,1.04 [0.98-1.11],0.197867369283616,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGA4,Pepsin A-4,Inverse variance weighted,7,1.11 [0.95-1.3],0.20520492773693,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.92 [0.81-1.05],0.214360846384108,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,1.04 [0.98-1.11],0.215210463495421,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,0.97 [0.93-1.02],0.216289359589916,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,1.19 [0.9-1.56],0.217984970692449,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.11 [0.94-1.33],0.220613751145295,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,1.19 [0.9-1.57],0.224436777243742,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.94 [0.86-1.04],0.227078231596917,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.3 [0.85-1.99],0.227909782352131,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD27,CD27 antigen,Inverse variance weighted,9,0.89 [0.73-1.08],0.22889309519118,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PI3,Elafin,Inverse variance weighted,18,0.96 [0.9-1.03],0.231670898987714,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,0.94 [0.85-1.04],0.233428646082597,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CBLN4,Cerebellin-4,Inverse variance weighted,17,1.04 [0.98-1.1],0.234163684336915,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,1.21 [0.88-1.65],0.23433132122952,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CFI,Complement factor I,Wald ratio,1,0.69 [0.37-1.27],0.235629604637148,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,0.9 [0.77-1.07],0.237091310703802,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PALM2,Paralemmin-2,Inverse variance weighted,9,1.05 [0.97-1.14],0.238410915658897,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.08 [0.95-1.23],0.240263764421377,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.06 [0.96-1.17],0.241725023174185,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.06 [0.96-1.17],0.242550768066707,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSM,Oncostatin-M,Inverse variance weighted,6,1.11 [0.93-1.31],0.243258892642058,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.2 [0.88-1.63],0.248654295086246,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN3,CCN family member 3,Inverse variance weighted,17,1.04 [0.97-1.1],0.25278731731987,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GUSB,Beta-glucuronidase,Inverse variance weighted,31,1.05 [0.97-1.13],0.254536927797285,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.82 [0.58-1.16],0.25651172613279,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.34 [0.81-2.22],0.257976936206688,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.96 [0.9-1.03],0.262687052963111,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,48,1.03 [0.98-1.09],0.262737842135418,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.92 [0.8-1.06],0.265914732635373,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,10,0.9 [0.75-1.08],0.266103349077101,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,27,1.05 [0.96-1.14],0.267436536497736,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,17,0.96 [0.88-1.04],0.270741961991291,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.84 [0.61-1.15],0.274509308459413,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.21 [0.86-1.69],0.274744992209134,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.19 [0.87-1.63],0.275589979337607,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.97 [0.91-1.03],0.282700069007152,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.89 [0.71-1.11],0.283308232438029,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,1.09 [0.93-1.29],0.284267625073708,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.15 [0.89-1.48],0.285687886879047,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.13 [0.9-1.41],0.286089756230526,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.09 [0.93-1.29],0.290313862294906,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGF,Placenta growth factor,Inverse variance weighted,5,1.09 [0.93-1.29],0.29096833625691,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.84 [0.61-1.16],0.293682186313962,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.12 [0.91-1.39],0.294062754099699,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OCLN,Occludin,Inverse variance weighted,2,1.17 [0.87-1.56],0.298132762821598,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.97 [0.93-1.02],0.298254274664761,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.91 [0.75-1.09],0.299770699005893,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGLN1,Egl nine homolog 1,Wald ratio,1,0.77 [0.48-1.26],0.302583717915597,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK4,Kallikrein-4,Inverse variance weighted,5,0.87 [0.67-1.13],0.302642778445829,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.95 [0.85-1.05],0.302936763158331,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.08 [0.93-1.24],0.306762305655235,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,1.17 [0.87-1.57],0.307071725049404,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NECTIN2,Nectin-2,Inverse variance weighted,3,1.19 [0.85-1.67],0.307110890592639,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.9 [0.73-1.1],0.310829493548292,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.91 [0.75-1.09],0.311273024277043,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGMN,Legumain,Inverse variance weighted,22,0.95 [0.85-1.05],0.312810448367893,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.05 [0.95-1.16],0.313578103541132,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNR,Tenascin-R,Inverse variance weighted,19,1.05 [0.96-1.14],0.315319603491799,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,0.93 [0.8-1.07],0.322272901449742,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PTN,Pleiotrophin,Inverse variance weighted,3,0.89 [0.72-1.12],0.324960609762787,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL17C,Interleukin-17C,Inverse variance weighted,5,1.11 [0.9-1.36],0.325538332772934,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.11 [0.9-1.36],0.33067648707899,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CES1,Liver carboxylesterase 1,Inverse variance weighted,19,0.95 [0.85-1.06],0.336678293268523,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPON1,Spondin-1,Inverse variance weighted,4,1.11 [0.9-1.37],0.338466297117099,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.05 [0.95-1.18],0.340339812625679,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.08 [0.92-1.27],0.341301944545983,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.12 [0.89-1.4],0.342344696387601,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.05 [0.95-1.17],0.343245823459343,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.96 [0.87-1.05],0.344821040815608,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.87 [0.65-1.16],0.34931656903192,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,1.05 [0.95-1.16],0.350409549430746,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,1.05 [0.95-1.16],0.351291454100802,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,1.1 [0.9-1.35],0.353084780147456,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.93 [0.8-1.08],0.353538488696975,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.02 [0.98-1.05],0.353775307106116,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.07 [0.93-1.23],0.354069176507465,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.93 [0.8-1.08],0.354524123961892,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.92 [0.76-1.1],0.360404681169388,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GLB1,Beta-galactosidase,Inverse variance weighted,9,0.89 [0.68-1.15],0.361196751667603,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.96 [0.88-1.05],0.361225800772503,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRSS8,Prostasin,Inverse variance weighted,14,0.93 [0.78-1.09],0.363731734125242,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.18 [0.82-1.7],0.365234369892332,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.09 [0.9-1.31],0.365603622135555,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.95 [0.85-1.06],0.366227395139638,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.1 [0.9-1.34],0.368394430237425,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.93 [0.8-1.09],0.368732400019785,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.35 [0.7-2.6],0.368742648820698,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.32 [0.72-2.42],0.372463055332948,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN1,CCN family member 1,Inverse variance weighted,6,1.07 [0.92-1.25],0.37373811531828,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.79 [0.48-1.32],0.375294715357819,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.85 [0.6-1.21],0.375549307985146,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.07 [0.92-1.24],0.382914605143184,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.08 [0.9-1.3],0.383706873349404,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.02 [0.97-1.07],0.383901371316305,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.95 [0.84-1.07],0.391416720772451,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP10,Stromelysin-2,Wald ratio,1,1.26 [0.75-2.12],0.392212375797901,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.07 [0.92-1.25],0.39512855627102,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSLN,Mesothelin,Inverse variance weighted,11,1.08 [0.9-1.31],0.397463827918557,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPA1,Pulmonary surfactant-associated protein A1,Inverse variance weighted,6,0.97 [0.91-1.04],0.397479147873429,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.93 [0.78-1.11],0.397939495255117,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,INSL3,Insulin-like 3,Inverse variance weighted,3,0.84 [0.57-1.25],0.398642872147773,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.97 [0.91-1.04],0.39947398282741,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CST3,Cystatin-C,Inverse variance weighted,3,0.89 [0.67-1.17],0.40582471511075,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.92 [0.76-1.12],0.405914846277818,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNTN1,Contactin-1,Inverse variance weighted,25,1.03 [0.95-1.12],0.409992597715674,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GAST,Gastrin,Inverse variance weighted,9,0.95 [0.85-1.07],0.411671563819903,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,0.93 [0.79-1.1],0.414230855213139,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.95 [0.85-1.07],0.420516125643158,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINA11,Serpin A11,Inverse variance weighted,14,0.93 [0.79-1.1],0.421011787026735,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.85 [0.56-1.27],0.424374498663933,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD276,CD276 antigen,Inverse variance weighted,24,0.97 [0.9-1.04],0.425451003264463,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.06 [0.91-1.24],0.429560943500465,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.17 [0.8-1.7],0.429987950221231,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.94 [0.81-1.1],0.434139160001762,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.97 [0.89-1.05],0.435820109162984,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.92 [0.75-1.13],0.43629716831227,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.03 [0.95-1.12],0.438719973758448,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MMP7,Matrilysin,Wald ratio,1,0.93 [0.77-1.12],0.439182958865141,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.92 [0.73-1.14],0.442666568421808,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.06 [0.92-1.22],0.444864881038579,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CALCA,Calcitonin,Inverse variance weighted,13,0.94 [0.79-1.11],0.447847718412312,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.01 [0.98-1.05],0.448497019579027,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1.04 [0.94-1.14],0.454171125455178,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,34,0.98 [0.92-1.04],0.454925601312231,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.93 [0.78-1.12],0.455329690811547,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.84 [0.54-1.32],0.456137785972986,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.9 [0.69-1.18],0.457057986196129,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,0.98 [0.94-1.03],0.457114604642764,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.93 [0.77-1.12],0.460518455752716,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,1.02 [0.97-1.06],0.461081694880378,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANG,Angiogenin,Inverse variance weighted,8,1.15 [0.79-1.67],0.469402139211914,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MDK,Midkine,Inverse variance weighted,14,1.07 [0.89-1.27],0.472684966347089,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.05 [0.92-1.2],0.476843492622879,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,5,0.91 [0.71-1.18],0.48172709295533,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.06 [0.9-1.24],0.483316163624033,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.14 [0.79-1.66],0.484770185409752,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.05 [0.92-1.2],0.487941236597575,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.01 [0.98-1.05],0.489659190821629,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.85 [0.54-1.34],0.494016150954541,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF9,Protein turtle homolog A,Inverse variance weighted,2,1.21 [0.7-2.12],0.495263645215051,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.92 [0.73-1.17],0.50150694405892,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSTN,Growth/differentiation factor 8,Inverse variance weighted,11,0.96 [0.84-1.09],0.502446426185738,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD48,CD48 antigen,Inverse variance weighted,14,0.96 [0.86-1.08],0.50246626201889,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.07 [0.87-1.31],0.504735748138889,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PSAP,Prosaposin,Inverse variance weighted,13,1.02 [0.96-1.1],0.506395318977731,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.97 [0.87-1.07],0.507864393068147,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS4,Galectin-4,Inverse variance weighted,15,0.98 [0.93-1.04],0.508177811310155,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.84 [0.5-1.41],0.513525963503779,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SEPTIN8,Septin-8,Inverse variance weighted,4,1.08 [0.85-1.39],0.517770862434156,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.03 [0.95-1.11],0.517811463767755,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.96 [0.86-1.08],0.522616393307415,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.03 [0.94-1.14],0.523224937061123,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.92 [0.71-1.19],0.523807518105446,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,0.92 [0.71-1.19],0.526211494393998,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NCAM1,Neural cell adhesion molecule 1,Inverse variance weighted,10,1.07 [0.88-1.3],0.52752169398612,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.08 [0.84-1.39],0.53073913541789,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.07 [0.87-1.3],0.531265986589929,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.05 [0.91-1.21],0.531724291303046,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.96 [0.86-1.08],0.531851906186704,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,46,0.99 [0.96-1.02],0.53452383301993,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,F9,Coagulation factor IX,Inverse variance weighted,3,0.85 [0.51-1.41],0.534950874635755,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,0.96 [0.84-1.1],0.535024022202971,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,1.04 [0.92-1.18],0.540098835780149,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.04 [0.91-1.2],0.54550230290405,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNC,Tenascin,Inverse variance weighted,57,0.99 [0.96-1.02],0.549952910131045,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.94 [0.77-1.15],0.55176082767949,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.08 [0.84-1.38],0.552054968134228,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.05 [0.89-1.23],0.554337188041875,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.06 [0.87-1.3],0.554761384221085,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.99 [0.97-1.02],0.559488823324391,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.09 [0.82-1.45],0.560630281487638,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KLK10,Kallikrein-10,Wald ratio,1,1.17 [0.68-2.02],0.562387415140225,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL18,Interleukin-18,Inverse variance weighted,26,1.02 [0.95-1.09],0.56334810512069,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MME,Neprilysin,Inverse variance weighted,46,1.01 [0.97-1.06],0.563359207952988,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.18 [0.67-2.08],0.563966489699277,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDH2,Cadherin-2,Inverse variance weighted,21,0.97 [0.86-1.09],0.565299494498839,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,1.09 [0.81-1.48],0.566782140423081,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.94 [0.77-1.16],0.568488573621179,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.96 [0.83-1.11],0.569218191761971,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FUOM,Fucose mutarotase,Inverse variance weighted,6,0.95 [0.81-1.12],0.57801174971754,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.05 [0.87-1.27],0.578200631996512,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GSN,Gelsolin,Inverse variance weighted,7,0.96 [0.83-1.11],0.582171147093131,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CDHR2,Cadherin-related family member 2,Inverse variance weighted,13,1.06 [0.86-1.3],0.588308794235264,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.06 [0.86-1.31],0.592535166667811,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KYNU,Kynureninase,Inverse variance weighted,3,0.87 [0.5-1.48],0.598402324661215,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLGN,Calmegin,Inverse variance weighted,6,1.03 [0.92-1.16],0.599127178907436,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.05 [0.88-1.24],0.60024659103668,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1.1 [0.76-1.61],0.604842408009612,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.99 [0.96-1.02],0.609577491247465,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,1.05 [0.87-1.27],0.610634006468721,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.97-1.05],0.61065871079355,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,1.07 [0.83-1.38],0.614033204343764,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.03 [0.93-1.13],0.617022923987877,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPON2,Spondin-2,Inverse variance weighted,3,1.09 [0.77-1.54],0.617934036826556,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.93 [0.69-1.25],0.618456176971586,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CREG1,Protein CREG1,Inverse variance weighted,20,1.01 [0.97-1.05],0.619441328782615,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.02 [0.95-1.1],0.620781704914878,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.92 [0.66-1.28],0.623293122101369,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.96 [0.8-1.15],0.624823140465514,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.98 [0.93-1.05],0.625556815939909,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.96 [0.82-1.13],0.625604200037174,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PYY,Peptide YY,Inverse variance weighted,16,0.98 [0.9-1.07],0.627036023508675,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,0.95 [0.77-1.17],0.632670478504253,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC3B,Tetranectin,Inverse variance weighted,2,0.79 [0.3-2.06],0.633944022274176,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.93 [0.7-1.25],0.641395023981974,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,6,0.96 [0.81-1.14],0.641784551370945,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD248,Endosialin,Inverse variance weighted,17,0.98 [0.89-1.08],0.643108368413043,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.02 [0.94-1.11],0.643262424911728,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.02 [0.93-1.12],0.644630712512769,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.97 [0.85-1.1],0.644692699045011,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.96 [0.82-1.13],0.646653821065809,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MVK,Mevalonate kinase,Wald ratio,1,0.78 [0.27-2.24],0.648947938220919,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.89 [0.54-1.47],0.64920108167531,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.94 [0.74-1.21],0.649519769293158,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.97 [0.86-1.1],0.655708579507554,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.05 [0.85-1.29],0.656558214379966,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FURIN,Furin,Inverse variance weighted,3,0.9 [0.57-1.43],0.656842284573327,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.06 [0.83-1.35],0.660710248353135,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.93-1.05],0.661196734375116,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.02 [0.93-1.13],0.663126438947821,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.03 [0.89-1.2],0.665204436757221,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,24,1.02 [0.93-1.13],0.665984387471632,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,APLP1,Amyloid-like protein 1,Inverse variance weighted,9,0.98 [0.89-1.08],0.673445738486905,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VWC2,Brorin,Inverse variance weighted,12,1.03 [0.9-1.18],0.673968826029174,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.95 [0.77-1.19],0.673985096514943,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.96 [0.81-1.15],0.67741290413957,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,0.99 [0.94-1.04],0.679264367270747,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,15,0.99 [0.95-1.04],0.679324053144189,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL11,Eotaxin,Inverse variance weighted,11,0.98 [0.92-1.06],0.684513508934716,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.97 [0.86-1.1],0.684763696221382,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.01 [0.97-1.05],0.685912321858436,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.02 [0.93-1.12],0.686442198154023,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.97 [0.84-1.12],0.686628759340783,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.06 [0.79-1.43],0.700987207766271,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,1.03 [0.9-1.18],0.702461368101391,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CST7,Cystatin-F,Inverse variance weighted,46,0.99 [0.94-1.04],0.703247962713352,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.03 [0.88-1.22],0.704339922325765,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MATN2,Matrilin-2,Inverse variance weighted,28,0.99 [0.95-1.03],0.705024487438186,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.95-1.03],0.710487834400844,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,0.99 [0.92-1.06],0.713726489010302,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.96 [0.77-1.2],0.716160022387679,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LAYN,Layilin,Inverse variance weighted,3,0.92 [0.6-1.42],0.716979139463276,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,1.01 [0.97-1.05],0.717006117298683,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.09 [0.68-1.76],0.724312946702271,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.96 [0.78-1.18],0.724499688199191,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.97 [0.83-1.14],0.724863170257789,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL15,Interleukin-15,Inverse variance weighted,35,0.99 [0.92-1.06],0.730037530196577,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.05 [0.81-1.35],0.732858156566383,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.03 [0.85-1.26],0.735361594702815,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.98 [0.88-1.09],0.742235952215281,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.98 [0.88-1.1],0.748337390752519,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.92 [0.54-1.56],0.751166917841027,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL32,Interleukin-32,Inverse variance weighted,9,0.97 [0.79-1.18],0.752151455466143,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL5,C-C motif chemokine 5,Inverse variance weighted,8,0.98 [0.86-1.12],0.752925904768702,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,0.99 [0.9-1.08],0.75366161974797,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,0.99 [0.95-1.04],0.760106857145685,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.97 [0.82-1.15],0.760942413633171,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,0.97 [0.77-1.21],0.76206166754999,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSD,Cathepsin D,Inverse variance weighted,7,0.97 [0.79-1.19],0.765669497942618,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.01 [0.96-1.05],0.765743473353126,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CTSF,Cathepsin F,Inverse variance weighted,27,1.01 [0.94-1.08],0.768868459233082,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.01 [0.94-1.08],0.76950513346546,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,10,1.02 [0.89-1.17],0.770105603532972,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NFASC,Neurofascin,Inverse variance weighted,6,0.97 [0.76-1.22],0.770559835160766,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.04 [0.8-1.35],0.783558709044458,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.97 [0.75-1.25],0.789254606043017,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.02 [0.88-1.18],0.789448083291035,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.98 [0.88-1.11],0.790702560981986,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.98 [0.87-1.11],0.796030871831257,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.02 [0.89-1.16],0.798224117925879,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.02 [0.87-1.2],0.799993390431403,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.97 [0.73-1.27],0.803643126229233,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.02 [0.88-1.19],0.805929604396402,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.99 [0.92-1.07],0.806645726180725,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,24,1.01 [0.95-1.07],0.810858563537141,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.01 [0.91-1.12],0.811398133850894,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.99 [0.89-1.1],0.811409400373046,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SELE,E-selectin,Inverse variance weighted,20,1 [0.97-1.04],0.811848460525985,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.07 [0.62-1.86],0.813946367462913,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,0.99 [0.95-1.04],0.815267716371576,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.99 [0.94-1.05],0.816292741768278,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,1.01 [0.94-1.09],0.819135936081768,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NT5E,5'-nucleotidase,Inverse variance weighted,45,0.99 [0.95-1.04],0.819473024341302,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,BCAN,Brevican core protein,Inverse variance weighted,12,1.02 [0.85-1.22],0.821816701465494,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,0.99 [0.93-1.06],0.823037911152993,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1 [0.95-1.04],0.825451010937619,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,26,1.01 [0.94-1.08],0.82596631375493,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.97 [0.72-1.3],0.826386120648184,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,0.98 [0.84-1.15],0.826989845649068,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD83,CD83 antigen,Inverse variance weighted,14,0.98 [0.84-1.15],0.827657631935995,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CAPG,Macrophage-capping protein,Wald ratio,1,0.96 [0.65-1.41],0.828449038377931,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NCAN,Neurocan core protein,Inverse variance weighted,19,0.99 [0.88-1.11],0.831607111900712,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.01 [0.89-1.16],0.83418813074177,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,1 [0.98-1.03],0.834992826674666,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.02 [0.86-1.2],0.837532066981336,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.02 [0.85-1.22],0.838400086308684,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.91-1.08],0.838503857676,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1.01 [0.95-1.07],0.839888569307455,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.97 [0.74-1.28],0.839943238633558,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.95 [0.6-1.52],0.842706360749821,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.99 [0.94-1.05],0.843066908280227,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LMNB2,Lamin-B2,Inverse variance weighted,8,1.02 [0.87-1.19],0.844269408975901,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.02 [0.86-1.2],0.847093372673396,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.01 [0.94-1.08],0.848028721859945,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.01 [0.92-1.1],0.849914429750223,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,UMOD,Uromodulin,Inverse variance weighted,34,0.99 [0.91-1.08],0.852262500004178,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.99 [0.84-1.16],0.853496758272272,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.02 [0.82-1.27],0.854501748410977,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.02 [0.82-1.26],0.854882215145761,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.99 [0.89-1.1],0.857961964024965,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.02 [0.84-1.24],0.85812518390883,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.99 [0.85-1.15],0.860523251585298,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.02 [0.85-1.21],0.864403973753512,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.98 [0.75-1.27],0.864453456115529,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.03 [0.74-1.44],0.864752095071202,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1 [0.94-1.05],0.864893564962426,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.99 [0.9-1.09],0.868651662846018,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.98 [0.74-1.3],0.868746414092552,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.98 [0.79-1.22],0.873248836741595,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,1.01 [0.92-1.1],0.876316432926354,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.01 [0.84-1.22],0.880433633129684,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,0.96 [0.6-1.56],0.883074762129663,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.99 [0.87-1.12],0.883861450016102,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.01 [0.87-1.18],0.885605725812421,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1 [0.95-1.05],0.885809132068662,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LGALS3,Galectin-3,Inverse variance weighted,15,1.01 [0.91-1.11],0.887449138365047,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.01 [0.91-1.11],0.88828812606734,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.95 [0.48-1.89],0.892399937946076,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,0.99 [0.85-1.15],0.897887848769357,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.99 [0.9-1.1],0.898710300452031,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.99 [0.79-1.23],0.904131835821296,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.03 [0.64-1.66],0.904244194826102,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1 [0.94-1.07],0.90426327282804,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.99 [0.82-1.2],0.905237123476653,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1 [0.97-1.04],0.908571445146487,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.02 [0.75-1.38],0.909505190794739,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,27,0.99 [0.9-1.09],0.910548277636861,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.01 [0.87-1.16],0.915608374327882,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.03 [0.61-1.74],0.919319530779622,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.98 [0.71-1.36],0.920685624203614,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,APCS,Serum amyloid P-component,Inverse variance weighted,3,0.98 [0.63-1.52],0.922434998152166,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.99 [0.72-1.34],0.929967149375065,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.99 [0.7-1.38],0.930781815804046,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.02 [0.71-1.44],0.931178338389868,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,16,1 [0.94-1.06],0.93244800195653,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CNTN5,Contactin-5,Inverse variance weighted,22,1 [0.93-1.07],0.932933632623321,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,1.01 [0.88-1.15],0.938530190702923,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,21,1 [0.89-1.13],0.940413478348296,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REN,Renin,Inverse variance weighted,8,1.01 [0.77-1.33],0.945571948510465,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,1 [0.93-1.07],0.948915896490559,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,1 [0.88-1.13],0.952481925149696,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,1 [0.85-1.16],0.952578071412374,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,AREG,Amphiregulin,Inverse variance weighted,5,1.01 [0.83-1.21],0.95457572982937,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,1 [0.9-1.12],0.95473650867179,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,GOLM2,Protein GOLM2,Inverse variance weighted,14,1 [0.94-1.07],0.957323320152488,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,0.99 [0.69-1.42],0.957691521081356,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1 [0.86-1.15],0.957718324396575,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.01 [0.81-1.24],0.959516376176566,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.98 [0.45-2.15],0.961918113797474,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1 [0.86-1.17],0.961953550267268,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCN4,CCN family member 4,Inverse variance weighted,29,1 [0.96-1.04],0.962423304895657,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1 [0.88-1.14],0.963208796617495,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1 [0.87-1.14],0.965672530217466,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1 [0.9-1.12],0.968752724089041,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,1 [0.95-1.05],0.9688737005721,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IL1RAP,Interleukin-1 receptor accessory protein,Inverse variance weighted,7,1 [0.81-1.23],0.970786560900045,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1 [0.97-1.04],0.974161309374817,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1 [0.88-1.14],0.974734614050831,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,1 [0.86-1.17],0.978259791142692,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1 [0.85-1.19],0.981343937603507,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1 [0.92-1.09],0.981667428754445,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1 [0.88-1.13],0.982370497791683,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1 [0.77-1.29],0.984477964028626,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1 [0.82-1.21],0.985500177699832,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,1 [0.9-1.12],0.98683514309839,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1 [0.74-1.36],0.987108055713557,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,1 [0.89-1.12],0.988628195840567,trans
Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1 [0.81-1.24],0.998788798162584,trans
